mRNA |
BX-912 |
GDSC1000 |
pan-cancer |
AAC |
0.012 |
0.7 |
mRNA |
PF-750 |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
elocalcitol |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.7 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
PF-4800567 hydrochloride |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.7 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
BRD-K84807411 |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.7 |
mRNA |
cimetidine |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.7 |
mRNA |
GSK429286A |
GDSC1000 |
pan-cancer |
AAC |
0.012 |
0.7 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.7 |